Form 8-K - Current report:
SEC Accession No. 0001396814-25-000048
Filing Date
2025-03-14
Accepted
2025-03-14 17:28:46
Documents
15
Period of Report
2025-03-12
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K pcrx-20250312.htm   iXBRL 8-K 26711
2 EX-3.1 ex-31thirdamendedandrestat.htm EX-3.1 137890
  Complete submission text file 0001396814-25-000048.txt   353609

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pcrx-20250312.xsd EX-101.SCH 2046
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT pcrx-20250312_def.xml EX-101.DEF 15768
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pcrx-20250312_lab.xml EX-101.LAB 28116
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pcrx-20250312_pre.xml EX-101.PRE 16530
17 EXTRACTED XBRL INSTANCE DOCUMENT pcrx-20250312_htm.xml XML 3861
Mailing Address 2000 SIERRA POINT PARKWAY SUITE 900 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY SUITE 900 BRISBANE CA 94005 650-242-8052
Pacira BioSciences, Inc. (Filer) CIK: 0001396814 (see all company filings)

EIN.: 510619477 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35060 | Film No.: 25741433
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)